Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Blood Advances|January 4, 2020
Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCTTalha Badar, Narendranath Epperla, Aniko Szabo, et al.
Journal for Immunotherapy of Cancer|October 9, 2025
Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapyPaolo Strati, Amanda Brandt, Anath C Lionel, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 2023
Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation TherapyPenny Fang, Chelsea C Pinnix, Susan Y Wu, et al.
Frontiers in Immunology|June 20, 2022
B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint BlockadeShubhra Singh, Jason Roszik, Neeraj Saini, et al.
Transplantation and Cellular Therapy|August 22, 2023
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell LymphomaHanan Alkhaldi, Alec Reinhardt, Melissa Barnett, et al.
Transplantation and Cellular Therapy|August 8, 2022
Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple MyelomaOren Pasvolsky, Denái R Milton, Mikael Rauf, et al.
Transplantation and Cellular Therapy|October 24, 2024
Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17pCurtis Marcoux, Oren Pasvolsky, Denái R Milton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 2, 2019
Age Is a Prognostic Factor for the Overall Survival of Patients with Multiple Myeloma Undergoing Upfront Autologous Hematopoietic Stem Cell TransplantationDavid M Cordas Dos Santos, Rima M Saliba, Romil Patel, et al.
Transplantation and Cellular Therapy|September 6, 2023
Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple MyelomaOren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Cancer|December 21, 2023
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantationOren Pasvolsky, Sarah Pasyar, Roland L Bassett, et al.
Pageof 6